Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
NIH Challenges' Real-World Evidence Innovation Challenge seeks to benchmark and validate analytic methods for clinical data, emphasizing reproducibility and robustness across diverse health systems.
FDA grant to fund a center researching complex generics, fostering collaboration between the FDA, industry, academia, and the public to improve access to generic drugs.
The NIH Complement Animal Research in Experimentation NAMs Reduction to Practice Challenge funds innovative, human-based NAMs to replace or supplement animal models in biomedical research.
Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing repurposed therapies to address unsolved diseases in underserved and priority patient groups.